International Conference on Gene Therapy and Clinical Applications
ICGTCA
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track will explore the latest methodologies in gene therapy, focusing on innovative approaches to enhance therapeutic efficacy. Discussions will include novel gene delivery systems and their implications for clinical applications.
SDG 3
SDG 4
This session will delve into the design and optimization of viral vectors for gene therapy applications. Participants will examine case studies highlighting the successes and challenges of using viral vectors in clinical settings.
SDG 3
SDG 9
This track will provide insights into somatic gene therapy, emphasizing its potential to treat a variety of genetic disorders. Presenters will discuss ongoing clinical trials and the regulatory landscape surrounding these therapies.
SDG 3
SDG 9
This session will focus on the identification and application of therapeutic genes in the treatment of genetic diseases. Researchers will present their findings on gene modulation and its impact on patient outcomes.
SDG 3
SDG 4
This track will review current clinical trials involving gene replacement strategies for genetic disorders. Experts will discuss the challenges faced in translating these strategies from bench to bedside.
SDG 3
SDG 9
This session will explore the intersection of molecular medicine and genetics, highlighting innovative approaches to diagnosing and treating genetic diseases. Participants will share insights on the role of molecular diagnostics in personalized medicine.
SDG 3
SDG 4
This track will compare ex vivo and in vivo gene therapy techniques, discussing their respective advantages and limitations. Case studies will illustrate the practical applications of both approaches in clinical settings.
SDG 3
SDG 4
This session will examine the role of gene therapy in regenerative medicine, focusing on its potential to repair or replace damaged tissues. Presentations will highlight recent breakthroughs and future prospects in this rapidly evolving field.
SDG 3
SDG 9
This track will investigate the synergistic potential of combining immunotherapy with gene therapy for enhanced therapeutic outcomes. Researchers will present data on how these approaches can work together to combat various diseases.
SDG 3
SDG 9
This session will focus on genome editing technologies and their applications in gene therapy. Experts will discuss the ethical considerations and potential regulatory challenges associated with genome correction.
SDG 3
SDG 4
This track will explore the principles of targeted therapy and gene modulation in the context of genetic diseases. Participants will share innovative strategies for enhancing the specificity and efficacy of therapeutic interventions.
SDG 3
SDG 4